Vulnerability in Bd Alaris Infusion Central

CVE-2022-47376

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.3 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L.

EPSS exploit prediction

EPSS: 0.002 (4.7th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 5th percentile — 4.7% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-47376: held from 0.002 to 0.002.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-47376?
CVE-2022-47376 is a high-severity vulnerability in Bd Alaris Infusion Central, classified under Storing Passwords in a Recoverable Format. CVSS score: 7.3/10. Published 2023-06-13.
How severe is CVE-2022-47376?
High severity. CVSS v3 base score is 7.3 out of 10.